The OncoDaily Cervical Cancer Summit 2026 is a global virtual medical congress dedicated entirely to cervical cancer screening, diagnosis, treatment, and elimination strategies, bringing together experts from all continents to discuss current standards of care and future directions on January 24, during Cervical Cancer Awareness Month.
Opening Addresses
The summit will open with keynote and special addresses from global leaders in cancer control and equity.
Zainab Shinkafi-Bagudu, President-Elect of the Union for International Cancer Control (UICC), is a global leader in cancer equity and childhood cancer advocacy. Her work focuses on strengthening cancer systems, improving access to care, and advancing global cancer elimination strategies.
Karen Canfell is the Lead of the Cancer Elimination Collaboration at the Sydney School of Public Health, The University of Sydney, Australia. She will deliver a keynote lecture about “Using Evidence to Save Lives via Cervical Cancer Elimination: Progress and Challenges to Date.” Prof. Canfell has played a pivotal role in shaping evidence-based cervical cancer screening policies and contributing to global cervical cancer elimination frameworks.
Lacy Hubbard is the Chief Executive Officer of the Elekta Foundation. She leads global initiatives to expand access to cancer care in low-resource settings, with a strong focus on women’s cancers, early detection, and sustainable radiotherapy capacity-building. With more than two decades of leadership experience in the radiotherapy industry, her work emphasizes scalable, cost-effective solutions and local ownership to advance global oncology equity.
Dilyara Kaidarova is a leading oncologist at the Kazakh Institute of Oncology, with extensive experience in cervical cancer prevention and screening programs. Her work reflects the evolution of cancer control strategies in Central Asia and their impact on population health.
Scientific Program Overview
This full-day meeting will cover the entire cervical cancer care pathway, including the evolution of screening programs, modern diagnostic strategies, and evidence-based treatment approaches across disease stages. Sessions will explore modern imaging approaches in cervical cancer diagnostics, the evolving role of surgery and radiotherapy, and contemporary medical oncology strategies for early-stage, locally advanced, and metastatic disease.
Dedicated masterclasses will address immunotherapy, antibody–drug conjugates, emerging targeted therapies, and the future of predictive biomarkers beyond PD-L1. The program also features a Global Voices section, highlighting real-world cervical cancer care across multiple regions, reflecting differences in access, resources, and outcomes worldwide.
| Images | Name | Time | Topic |
|---|---|---|---|
 | HE Dr. Zainab Shinkafi-Bagudu UICC President-Elect First Lady of Kebbi State, Founder of the Medicaid Cancer Foundation, Chairperson of First Ladies Against Cancer (FLAC), Global Initiative Against HPV and Cervical Cancer (GIAHC), Global Cancer Advocate | 10:0 am | Opening address |
 | Karen Canfell Lead, Cancer Elimination Collaboration, Sydney School of Public Health, The University of Sydney, Australia | 10:10 am | Using evidence to save lives via cervical cancer elimination - progress and challenges to date |
 | Nermeen MostafaHead of Awareness Subcommittee of Egyptian Presidential Initiative of Cancer Early Detection and Management,Consultant of Clinical Oncology at Gustave Roussy International Egypt | 10:40 am | HPV Vaccination and Cervical Cancer Prevention: What Works in Practice |
 | Dilyara Kaidarova Professor, First Vice-Rector Asfendiyarov Kazakh National Medical University President, Kazakhstan Cancer Society (KazCS) | 11:0 am | Cervical Cancer: The Role of Screening and the Current Situation in Kazakhstan |
 | Hovhannes Vardevanyan Radiologist, Head of Diagnostic Imaging Department, Armenian-American Wellness Center, Head of Radiology Service, Wigmore Hospital for Children Chairman of Scientific Board, EMERTE Clinic | 11:50 am | The Role of Imaging in Cervical Cancer Care: Current Practice and Future Directions |
 | Olena Postupalenko Oncogynecologist, Department of Minimally Invasive Surgery, Kyiv City Clinical Oncology Center, Ukraine ESO Ambassador in Ukraine | 12:10 pm | Surgery: The Evolving Role of Surgery in Early-Stage Disease |
 | Marija Zivkovic Assist. Prof. Marija Živković Radojević, MD, PhD, Radiation oncologist, Faculty of Medical Sciences, University of Kragujevac, Clinical Oncology Department, Kragujevac, Serbia University Clinical Center Kragujevac, Clinic for Radiation Oncology, Kragujevac, Serbia | 12:40 pm | Radiotherapy: Modern Radiotherapy Techniques |
 | Caruso Giuseppe Consultant - Division of Gynecologic Oncology - IEO (Milan, Italy)
PhD Candidate - Sapienza University (Rome, Italy)
Research Collaborator - Mayo Clinic, Rochester (MN, USA) | 1:0 pm | Role of Systemic Therapy in treating early-stage cervical cancer: What and when? |
 | Mansoor Raza Mirza Chief Medical Officer at Acrivon Therapeutics, USA | 1:20 pm | Role of Immunotherapy in Management of Localized Cervical Cancer |
 | Amil Družić Oncology Clinic, Clinical Center of Sarajevo University (KCUS), Sarajevo, Bosnia and Herzegovina European Cancer Organisation (ECO), HPV & Hep B Action Network — Vice-Chair, Brussels, Belgium | 1:50 pm | HPV & Cervical Cancer Prevention in South East Europe: progress, gaps, and priorities for 2026 |
 | Yan Li Chief Physician, Professor, Doctoral Supervisor, Department of Gynecology General Hospital of Ningxia Medical University, China | 2:10 pm | CACA guideline for the diagnosis and treatment of cervical cancer(2025 |
 | Maka Abuladze Medical Oncologist , Associate Professor , Tbilisi Medical Academy Todua Clinic, Tbilisi, Georgia | 2:30 pm | Current State of Cervical Cancer in Georgia |
 | Helena Kremer Clinical Oncologist, University Hospital Clementino Fraga Filho of the Federal University of Rio de Janeiro, Brazil | 2:45 pm | Current State of Cervical Cancer in Brazil |
 | Imene Hadji Medical Oncologist, EPH Ibn Zohr, Guelma, Algeria | 3:0 pm | Current State of Cervical Cancer in Algeria |
 | Salma Najem National Institute of cancer of Rabat, Morocco | 3:10 pm | Current State of Cervical Cancer in Morocco |
 | Brunilda Profka Haxhiu Clinical Oncologist Chief of Patient Admission in Radiotherapy Clinic of Oncology University Clinical Center of Kosovo | 3:25 pm | Current State of Cervical Cancer in Kosovo |
 | Brian Slomovitz Director, Gynecologic Oncology, Mount Sinai Medical Center Professor, Obstetrics and Gynecology, Florida International University Professor, Obstetrics and Gynecology, New York Medical College Member, Board of Directors, GOG Foundation Uterine Cancer Lead, GOG Partners | 3:40 pm | Novel Weapons in treating Cervical Cancer |
 | Oksana Mashevska Clinical Oncologist, Director of Oncology Department, Manufactura Clinic , Kiev, Ukraine | 4:0 pm | Current State of Cervical Cancer in Ukraine |
 | Ishak Lawal Consultant Obstetrician & Gynaecologist Federal Teaching Hospital Birnin-Kebbi, Nigeria | 4:20 pm | Current State of Cervical Cancer in Nigeria |
 | Enes Erul Medical Oncologist Ankara University CancerResearch Institute, Turkey | 4:35 pm | Current State of Cervical Cancer in Turkey |
 | Mariam Mailyan Medical Oncologist, Yeolayn Hematology and Oncology Center, D’Clinic, Armenia | 4:55 pm | Current State of Cervical Cancer in Armenia |
 | Lacy Hubbard CEO, Elekta Foundation | 5:10 pm | Acting Fast to Eliminate Cervical Cancer |
 | Maria Tzima Board Member of ELLOK, The Hellenic Cancer Federation, Greece | 5:40 pm | Role of Policymakers in Cervical Cancer |
 | Amol Akhade Medical Oncologist, Fortis Hospital Mumbai, India | 6:0 pm | Panel |
 | Emad Shash Medical Oncologist, Director of the Breast Cancer Comprehensive Center, National Cancer Institute, Cairo Egypt | 6:0 pm | Panel |
 | Abeid Athman Omar Clinical Oncologist, Head of Department, Kenyatta University Teaching, Referral and Research Hospital, Kenya | 6:0 pm | Panel |
 | Martin Harutyunyan Lead of OncoDaily LA | 6.00 pm | Panel |
The OncoDaily Cervical Cancer Summit is designed for medical oncologists, gynecologic oncologists, radiation oncologists, radiologists, surgeons, researchers, and public health professionals seeking a comprehensive and up-to-date global perspective on cervical cancer management in 2026.
The meeting emphasizes evidence-based practice, multidisciplinary collaboration, and implementation science, aligning clinical advances with global elimination goals, including the 90-70-90 targets.
Event Details
Date: January 24, 2026
Format: Virtual Summit
Registration: Link to Register
Live Streaming: LinkedIn | YouTube | X
A full day dedicated to cervical cancer science, screening, treatment, and global realities, featuring expert voices from around the world.